These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31344071)

  • 1. Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13.
    Bestwick JP; Wald NJ
    PLoS One; 2019; 14(7):e0220053. PubMed ID: 31344071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal reflex DNA screening for trisomies 21, 18, and 13.
    Wald NJ; Huttly WJ; Bestwick JP; Old R; Morris JK; Cheng R; Aquilina J; Peregrine E; Roberts D; Alfirevic Z
    Genet Med; 2018 Aug; 20(8):825-830. PubMed ID: 29120460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model-based analysis.
    Le Bras A; Salomon LJ; Bussières L; Malan V; Elie C; Mahallati H; Ville Y; Vekemans M; Durand-Zaleski I
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):596-603. PubMed ID: 31006923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal reflex DNA screening for trisomy 21, 18 and 13.
    Wald NJ
    Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889
    [No Abstract]   [Full Text] [Related]  

  • 7. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal reflex DNA screening for trisomy 18 and trisomy 13 in addition to Down's syndrome.
    Bestwick JP; Wald NJ
    J Med Screen; 2016 Dec; 23(4):171-174. PubMed ID: 26790709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis.
    Prefumo F; Paolini D; Speranza G; Palmisano M; Dionisi M; Camurri L
    PLoS One; 2019; 14(6):e0218166. PubMed ID: 31188879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.
    Wongkrajang P; Jittikoon J; Sangroongruangsri S; Talungchit P; Ruangvutilert P; Panchalee T; Chaikledkaew U
    PLoS One; 2023; 18(4):e0284829. PubMed ID: 37079630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
    Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
    Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
    Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
    Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
    Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.